Sana Biotechnology Inc (SANA)
NASDAQ
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -86.19M | -81.79M | -84.05M | -116.29M | -2.18M | -90.62M | -110.72M | -49.37M |
Pre Tax Income | -85.12M | -80.44M | -82.12M | -114M | 984k | -88.12M | -107.48M | -50.29M |
Net Income | -85.12M | -80.44M | -82.12M | -114M | 984k | -88.12M | -107.48M | -50.29M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -86.29M | -82.06M | -84.1M | -116.37M | -2.01M | -90.67M | -110.51M | -53.49M |
EBITDA | -82.17M | -77.59M | -79.71M | -111.84M | 2.32M | -79.36M | -106.98M | -45.48M |
Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -13.25M | -141.15M | -286.15M | -367.98M | -272.56M | -293.14M |
Pre Tax Income | -13.25M | -138.33M | -285.31M | -367M | -269.48M | -283.26M |
Net Income | -13.25M | -130.78M | -285.31M | -367M | -269.48M | -283.26M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -2.099 | -3.268 | -17.644 | -1.985 | -1.411 | -1.437 |
EBIT | -13.25M | -141.18M | -286.05M | -367.67M | -273.24M | -293.19M |
EBITDA | -13.25M | -139.33M | -280.23M | -356.91M | -256.94M | -268.58M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.